Skip to content

REGN

Regeneron Pharmaceuticals, Inc.

Revenue by product

2025, ended Dec 31, 2025

Earlier:

Products by fiscal year

Products by fiscal year
Line, in USD2025202420232022202120202019201820172016
Collaboration revenue7.33B6.06B5.50B4.91B3.67B1.19B————
Net product sales6.3B7.6B7.1B6.9B12.1B5.6B4.8B———
Libtayo
1.45B1.22B0.86B0.45B0.31B0.27B0.18B15M——
Praluent
263M242M182M130M170M151M————
Evkeeza
162M126M77M49M18M—————
Other products
10M—————————
ELYEA HD And EYLEA
4.38B5.97B5.89B———————
Inmazeb
37M77M70M3.0M——————
Regen-cov
————5.83B0.19B————
Arcalyst
————2.2M13M15M15M17M15M
Eylea2.75B4.77B5.72B6.26B5.79B4.95B4.64B4.08B3.70B3.32B
Other revenue703M515M536M365M281M557M174M———
—————1.19B1.55B1.04B2.15B1.52B
Total14.3B14.2B13.1B12.2B16.1B8.5B6.6B5.1B5.9B4.9B